Lotz Christopher L. (CIK 0001812553)

Latest company ownership

Shares held
100,000
Last filed at
Aug 4, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 16, 2021 Apr 19, 2021 Qualigen Therapeutics, Inc. CFO Buy 90.0 +2,700 27.44% ✗ $5K